Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils | The Manila Times
VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) ('HYTN” or the 'Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.
Ähnliche Seiten
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany | The Manila Times
https://www.manilatimes.net/2026/04/18/tmt-newswire/globenewswire/hytn-introduces-hard-remediation-to-gmp-processing-services-releases-product-in-germany/2323088HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder | The Manila Times
https://www.manilatimes.net/2026/03/28/tmt-newswire/globenewswire/hytn-successfully-releases-cannabis-products-in-germany-and-accepts-reorder/2309690HYTN Appoints Fabian Monaco to Board of Directors | The Manila Times
https://www.manilatimes.net/2026/03/21/tmt-newswire/globenewswire/hytn-appoints-fabian-monaco-to-board-of-directors/2304728